Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
ICD Research
6 / 2012
66 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of revenuue growth of global pharmaceutical industry.
• Analysis of future expectations for the growth prospects of pharmaceutical companies.
Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. In this report, executives provide their future expectations for the growth prospects of their companies as well as insight into the type and likelihood of structural changes in the competitive landscape in terms of mergers and acquisitions, and business structure. This provides a snapshot of business outlook and the mood across the industry. Industry trends have also been analyzed in comparison with the results of ICD Research’s 2011 and 2010industry surveys, providing the opportunity to track changes in respondents’ attitudes.
Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• This report covers data and analysis on revenue growth expectations of global pharmaceutical companies.
Reasons To Buy
• This report will help you to understand revenue growth projections of global pharmaceutical industry.
• This report will help you to understand future developments in business structure from buyers and suppliers point of view.
• This report will help you to better understand the M&A activity of the global pharmaceutical industry.
• This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
Companies Mentioned:
NA
Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of revenuue growth of global pharmaceutical industry.
• Analysis of future expectations for the growth prospects of pharmaceutical companies.
Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. In this report, executives provide their future expectations for the growth prospects of their companies as well as insight into the type and likelihood of structural changes in the competitive landscape in terms of mergers and acquisitions, and business structure. This provides a snapshot of business outlook and the mood across the industry. Industry trends have also been analyzed in comparison with the results of ICD Research’s 2011 and 2010industry surveys, providing the opportunity to track changes in respondents’ attitudes.
Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• This report covers data and analysis on revenue growth expectations of global pharmaceutical companies.
Reasons To Buy
• This report will help you to understand revenue growth projections of global pharmaceutical industry.
• This report will help you to understand future developments in business structure from buyers and suppliers point of view.
• This report will help you to better understand the M&A activity of the global pharmaceutical industry.
• This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
Companies Mentioned:
NA
Inhaltsverzeichnis - Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Global Pharmaceutical Industry Dynamics
2.1 Revenue Growth Expectations in the Global Pharmaceutical Industry
2.1.1 Global pharmaceutical industry: revenue growth expectations by company type
2.1.2 Global pharmaceutical industry: revenue growth expectations by region
2.1.3 Global pharmaceutical industry: revenue growth expectations by turnover
2.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
2.1.5 Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons
2.2 Future Developments in Business Structure: Global Pharmaceutical Industry
2.2.1 Global pharmaceutical industry: future developments by buyers
2.2.2 Global pharmaceutical industry: future developments by suppliers
2.2.3 Global pharmaceutical industry: future developments by region
2.2.4 Global pharmaceutical industry: future developments by company turnover
2.3 M&A Activity Projections in the Global Pharmaceutical Industry
2.3.1 M&A activity projections in the global pharmaceutical industry by buyers
2.3.2 M&A activity projections in the global pharmaceutical industry by suppliers
2.3.3 M&A activity projections in the global pharmaceutical industry by region
2.3.4 M&A activity projections in the global pharmaceutical industry by company turnover
2.3.5 Global pharmaceutical industry: expansion abroad vs M&A activity projections
2.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry
2.4.1 Capital expenditure forecast in the global pharmaceutical industry by buyers
2.4.2 Capital expenditure forecast in the global pharmaceutical industry by suppliers
2.4.3 Capital expenditure forecast in the global pharmaceutical industry by region
2.4.4 Capital expenditure forecast in the global pharmaceutical industry by company turnover
2.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry
2.5.1 Global pharmaceutical industry: planned change in staff recruitment activity by buyers
2.5.2 Global pharmaceutical industry: planned change in staff recruitment activity by suppliers
2.5.3 Global pharmaceutical industry: planned change in staff recruitment activity by region
2.5.4 Global pharmaceutical industry: planned change in staff recruitment activity by company turnover
3 Appendix
3.1 Global Pharmaceutical Industry Survey Results - Closed Questions
3.2 Methodology
3.3 Contact us
3.4 About ICD Research
3.5 Disclaimer
Tabellenverzeichnis - Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010-2012
Table 9: Global Pharmaceutical Industry Revenue Growth Optimism by Buyers (%), 2010-2012
Table 10: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010-2012
Table 11: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Table 12: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Table 13: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Table 14: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Table 15: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Table 16: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Table 17: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Table 18: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010-2012
Table 19: M&A Projections: Global CRO and CMO (%), 2010-2012
Table 20: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 21: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Table 22: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Table 23: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Table 24: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Table 25: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Table 26: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Table 27: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Table 28: Staff Recruitment by Global Pharmaceutical Industry Suppliers (%), 2012
Table 29: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Table 30: Global Pharmaceutical Industry Staff Recruitment by Turnover (%), 2012
Table 31: Survey Results - Closed Questions
Übersichtenverzeichnis - Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
Figure 1: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010-2012
Figure 2: Global Pharmaceutical Industry Revenue Growth Optimism by Company Type(%), 2010-2012
Figure 3: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010-2012
Figure 4: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Figure 5: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Figure 6: Revenue Growth Optimism: Cross Industry Comparison (%), 2012
Figure 7: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Figure 8: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Figure 9: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Figure 10: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Figure 11: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Figure 12: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010-2012
Figure 13: M&A Projections: Global CRO and CMO Industry (%), 2010-2012
Figure 14: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Figure 15: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Figure 16: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Figure 17: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Figure 18: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Figure 19: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Figure 20: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Figure 21: Global Pharmaceutical Industry Capital Expenditure Forecast by Region (%), 2012
Figure 22: Global Pharmaceutical Industry Capital Expenditure Forecast by Turnover (%), 2012
Figure 23: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Figure 24: Planned Change in Staff Hiring Activities by Pharmaceutical Industry Suppliers (%), 2012
Figure 25: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Figure 26: Planned Change in Staff Hiring Activities by Company Turnover (%), 2012
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Global Pharmaceutical Industry Dynamics
2.1 Revenue Growth Expectations in the Global Pharmaceutical Industry
2.1.1 Global pharmaceutical industry: revenue growth expectations by company type
2.1.2 Global pharmaceutical industry: revenue growth expectations by region
2.1.3 Global pharmaceutical industry: revenue growth expectations by turnover
2.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
2.1.5 Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons
2.2 Future Developments in Business Structure: Global Pharmaceutical Industry
2.2.1 Global pharmaceutical industry: future developments by buyers
2.2.2 Global pharmaceutical industry: future developments by suppliers
2.2.3 Global pharmaceutical industry: future developments by region
2.2.4 Global pharmaceutical industry: future developments by company turnover
2.3 M&A Activity Projections in the Global Pharmaceutical Industry
2.3.1 M&A activity projections in the global pharmaceutical industry by buyers
2.3.2 M&A activity projections in the global pharmaceutical industry by suppliers
2.3.3 M&A activity projections in the global pharmaceutical industry by region
2.3.4 M&A activity projections in the global pharmaceutical industry by company turnover
2.3.5 Global pharmaceutical industry: expansion abroad vs M&A activity projections
2.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry
2.4.1 Capital expenditure forecast in the global pharmaceutical industry by buyers
2.4.2 Capital expenditure forecast in the global pharmaceutical industry by suppliers
2.4.3 Capital expenditure forecast in the global pharmaceutical industry by region
2.4.4 Capital expenditure forecast in the global pharmaceutical industry by company turnover
2.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry
2.5.1 Global pharmaceutical industry: planned change in staff recruitment activity by buyers
2.5.2 Global pharmaceutical industry: planned change in staff recruitment activity by suppliers
2.5.3 Global pharmaceutical industry: planned change in staff recruitment activity by region
2.5.4 Global pharmaceutical industry: planned change in staff recruitment activity by company turnover
3 Appendix
3.1 Global Pharmaceutical Industry Survey Results - Closed Questions
3.2 Methodology
3.3 Contact us
3.4 About ICD Research
3.5 Disclaimer
Tabellenverzeichnis - Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010-2012
Table 9: Global Pharmaceutical Industry Revenue Growth Optimism by Buyers (%), 2010-2012
Table 10: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010-2012
Table 11: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Table 12: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Table 13: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Table 14: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Table 15: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Table 16: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Table 17: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Table 18: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010-2012
Table 19: M&A Projections: Global CRO and CMO (%), 2010-2012
Table 20: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 21: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Table 22: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Table 23: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Table 24: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Table 25: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Table 26: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Table 27: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Table 28: Staff Recruitment by Global Pharmaceutical Industry Suppliers (%), 2012
Table 29: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Table 30: Global Pharmaceutical Industry Staff Recruitment by Turnover (%), 2012
Table 31: Survey Results - Closed Questions
Übersichtenverzeichnis - Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
Figure 1: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010-2012
Figure 2: Global Pharmaceutical Industry Revenue Growth Optimism by Company Type(%), 2010-2012
Figure 3: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010-2012
Figure 4: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Figure 5: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Figure 6: Revenue Growth Optimism: Cross Industry Comparison (%), 2012
Figure 7: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Figure 8: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Figure 9: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Figure 10: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Figure 11: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Figure 12: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010-2012
Figure 13: M&A Projections: Global CRO and CMO Industry (%), 2010-2012
Figure 14: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Figure 15: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Figure 16: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Figure 17: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Figure 18: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Figure 19: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Figure 20: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Figure 21: Global Pharmaceutical Industry Capital Expenditure Forecast by Region (%), 2012
Figure 22: Global Pharmaceutical Industry Capital Expenditure Forecast by Turnover (%), 2012
Figure 23: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Figure 24: Planned Change in Staff Hiring Activities by Pharmaceutical Industry Suppliers (%), 2012
Figure 25: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Figure 26: Planned Change in Staff Hiring Activities by Company Turnover (%), 2012
- Calming and Sleeping in Canada
- Calming and Sleeping in Denmark
- Calming and Sleeping in Hong Kong, China
- Calming and Sleeping in Norway
- Calming and Sleeping in Turkey
- Cough, Cold and Allergy (Hay Fever) Remedies in Canada
- Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
- Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
- Cough, Cold and Allergy (Hay Fever) Remedies in Norway
- Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
- Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
- Ear Care in Canada
- Ear Care in Denmark
- Ear Care in Hong Kong, China
- Ear Care in Norway
- Emergency Contraception in Canada
- Emergency Contraception in Denmark
- Emergency Contraception in Norway
- Global Vaccine Market
- Health and Beauty Specialist Retailers in Saudi Arabia
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:
Seite drucken
Seite empfehlen
Home | Werbung | Über marktforschung.de | AGB | Impressum | Sitemap | Suche © 2006 bis 2013 Alle Rechte bei marktforschung.de - Studie - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief - Marktdaten / Marktanalysen bei marktforschung.de